Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.080
-0.100 (-8.47%)
At close: Oct 29, 2024, 4:00 PM
1.090
+0.010 (0.93%)
After-hours: Oct 29, 2024, 7:55 PM EDT

Calidi Biotherapeutics Stock Forecast

CLDI's stock price has decreased by -95.4% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for CLDI stock have an average target of 16.67, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 1,443.52% from the current stock price of 1.08.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $16.67 $20 $20
Change +825.93% +1443.5% +1751.9% +1751.9%
* Price targets were last updated on Jun 27, 2024.

Analyst Ratings

The average analyst rating for CLDI stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 122222
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 233333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$10
Strong Buy Initiates $10 +825.93% Jun 27, 2024
Baird
Baird
Buy
Maintains
$45$20
Buy Maintains $45$20 +1,751.85% May 15, 2024
Baird
Baird
Buy
Maintains
$90$45
Buy Maintains $90$45 +4,066.67% Mar 21, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$110$20
Strong Buy Maintains $110$20 +1,751.85% Mar 21, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$110
Strong Buy Initiates $110 +10,085.19% Nov 22, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.07
from -17.30
EPS Next Year
-1.82
from -5.07
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-449.00K45.00K-----
Revenue Growth
---89.98%-----
EPS
-4.63-5.54-29.90-17.30-5.07-1.82-1.73-
EPS Growth
--------
Forward PE
--------
No. Analysts ----4443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -3.93 -0.81 -0.53
Avg -5.07 -1.82 -1.73
Low -6.08 -2.74 -2.84

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.